Association of BclI polymorphism of the glucocorticoid receptor gene locus with response to glucocorticoids in inflammatory bowel disease

The publication of the iron deficiency guidelines in 20051 and the adoption of iron deficiency anaemia (IDA) as a 2-week referral criterion by the National Institute for Clinical Excellence lower gastrointestinal (GI) cancer guidelines2 should have focused attention on this historically poorly managed condition. There is evidence from the primary care literature of poor adherence to previous IDA guidelines.3 In order to evaulate adherence to the new IDA guidelines in our trust, we undertook a short prospective audit of all patients admitted in 1 month through …

[1]  A. Zinsmeister,et al.  A population‐based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis , 2006, Inflammatory bowel diseases.

[2]  A. Griffiths,et al.  The natural history of corticosteroid therapy for ulcerative colitis in children. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[3]  S. Martelossi,et al.  Glucocorticoid receptor polymorphisms in inflammatory bowel disease. , 2006, Gut.

[4]  R. Derijk,et al.  Corticosteroid receptor genetic polymorphisms and stress responsivity , 2005, Endocrine.

[5]  N. Bhala,et al.  Association of Adult Celiac Disease With Surgical Abdominal Pain: A Case-Control Study in Patients Referred to Secondary Care , 2005, Annals of surgery.

[6]  G. Porro,et al.  A rare cause of diuretic refractory ascites , 2005, Gut.

[7]  Teresa L. Sedgley,et al.  Glucocorticoid receptor polymorphisms and post-traumatic stress disorder , 2005, Psychoneuroendocrinology.

[8]  R. Stewart,et al.  Iron deficiency anaemia in general practice: clinical outcomes over three years and factors influencing diagnostic investigations , 2004, Postgraduate Medical Journal.

[9]  D. Kelleher,et al.  Glucocorticoid resistance in inflammatory bowel disease. , 2003, The Journal of endocrinology.

[10]  I. Shapira,et al.  The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. , 2001, Journal of the American College of Cardiology.

[11]  C. Meisel,et al.  Frequency of single nucleotide polymorphisms in the P‐glycoprotein drug transporter MDR1 gene in white subjects , 2001, Clinical pharmacology and therapeutics.

[12]  P. Keeling,et al.  High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. , 2000, Gastroenterology.

[13]  D. Jewell,et al.  Coeliac disease in primary care: case finding study , 1999, BMJ.

[14]  J. Connell,et al.  Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. , 1998, The Journal of clinical endocrinology and metabolism.

[15]  D. Grobbee,et al.  Lack of association between five polymorphisms in the human glucocorticoid receptor gene and glucocorticoid resistance , 1997, Human Genetics.

[16]  P. Munkholm,et al.  Frequency of glucocorticoid resistance and dependency in Crohn's disease. , 1994, Gut.

[17]  S. Kreiner,et al.  Alimentary tract andpancreas Prognosis inCrohn's disease -based onresults froma regional patient group fromthecounty ofCopenhagen , 1985 .

[18]  T. Sakaeda.  MDR1 genotype-related pharmacokinetics: fact or fiction? , 2005, Drug metabolism and pharmacokinetics.

[19]  H. Colhoun,et al.  Health Survey for England 1994 , 1994 .